中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
Two production lines of Henan Lianmu Veterinary Medicine Co., Ltd. passed the veterinary drug GMP approval
Date：2025-03-26
Views：370
From March 25 to 26, two production lines of Henan Lianmu Veterinary Medicine Co., Ltd. passed the veterinary drug GMP approval.
Previous：
Bayannur Municipal Government held a high-level symposium with TUL company's senior executives
Next：
Revenue Reaches RMB 13.759 Billion! TUL announced Full-Year 2024 financial results
WeChat
Official
Account
To Top
粤公网安备44040402000348号